The Supreme Court Decision on the 340B Drug Program - McDermott+Consulting

The Supreme Court Decision on the 340B Drug Program

Last Wednesday, the Supreme Court issued its long-awaited decision on the Medicare 340B payment cut case (AHA v. Becerra). The Court found that HHS’s 340B drug payment cuts in 2018 and 2019 were unlawful and sent the case back to the D.C. District Court for further deliberations. Emily Cook and Rodney Whitlock visit this week to explain how this decision impacts 340B hospitals and what litigation remains surrounding the payment cut.